Andrew Hessel: Difference between revisions
No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
=== Contact Information === | === Contact Information === | ||
email: ahessel (at) gmail (dot) com | email: ahessel (at) gmail (dot) com | ||
phone: 780.868.3169 | |||
Skype: search for "Andrew Hessel", ahessel (at) gmail (dot) com | Skype: search for "Andrew Hessel", ahessel (at) gmail (dot) com | ||
| Line 23: | Line 24: | ||
Andrew Hessel | Andrew Hessel | ||
c/o Alberta Ingenuity | |||
Suite 2410, Manulife Place | |||
10180 - 101 Street | |||
Edmonton, Alberta | |||
T5J 3S4 | |||
== 2007 Talks == | == 2007 Talks == | ||
Revision as of 19:27, 2 February 2007
Andrew and Stephanie, Banff, Alberta, January 2006
About
I am a consulting biologist and author interested in synthetic biology and open source biology. To my mind, DNA is a programming language that scientists have been working to reverse engineer with increasing success. Synthetic biology allows forward engineering, permitting scientists to write code de novo and allowing logical, fully understandable evolution of biological outputs ranging from single proteins to, eventually, synthetic cells and synthetic organisms. I advocate the use of open source principles because in software development these ideas have led to robust code, highly skilled developer communities, and non-monopolistic pricing. If the same results can be achieved in genome engineering, it could potentially create a more diversified and sustainable biotechnology industry. These ideas are explored in Open Sources 2.0, published by O'Reilly.
Background
I received my MSc. in bacterial genomics from the University of Calgary in 1995. I joined the Amgen Institute, a 120 person research facility located in Toronto, Canada, as a bioinformaticist and manager. Working as a bridge between the Institute, Amgen Canada, and Amgen Inc. (Thousand Oaks, CA), I facilitated dozens of advanced research projects involving microarrays, genetic sequence analysis, and data mining. Today, the Institute, no longer affiliated with Amgen, is known as the Campbell Family Institute for Breast Cancer Research. In 2002, I co-founded of Miikana Therapeutics and helped create the virtual business model they successfully used. Miikana was sold to Entremed in December, 2005 for $21 million plus milestones.
Contact Information
email: ahessel (at) gmail (dot) com phone: 780.868.3169
Skype: search for "Andrew Hessel", ahessel (at) gmail (dot) com
Letter post:
Andrew Hessel c/o Alberta Ingenuity Suite 2410, Manulife Place 10180 - 101 Street Edmonton, Alberta T5J 3S4
2007 Talks
Alberta Ingenuity, January 17/18
